Literature DB >> 22326581

Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion.

Veronica Santarlasci1, Laura Maggi, Manuela Capone, Valentina Querci, Luca Beltrame, Duccio Cavalieri, Elena D'Aiuto, Rolando Cimaz, Angela Nebbioso, Francesco Liotta, Raffaele De Palma, Enrico Maggi, Lorenzo Cosmi, Sergio Romagnani, Francesco Annunziato.   

Abstract

The reason why CD4(+) T helper 17 (Th17) cells, despite their well-known pathogenic role in chronic inflammatory disorders, are very rare in the inflammatory sites remains unclear. We demonstrate that human Th17 cells exhibit low ability to proliferate and to produce the T cell growth factor interleukin-2 (IL-2), in response to combined CD3 and CD28 stimulation. This was due to the upregulated expression of IL-4-induced gene 1 (IL4I1) mRNA, a secreted L-phenylalanine oxidase, which associated with a decrease in CD3ζ chain expression and consequent abnormalities in the molecular pathway that allows IL-2 production and cell proliferation. High IL4I1 mRNA expression was detectable in Th17 cell precursors and was strictly dependent on Th17 cell master gene, the retinoid acid related orphan receptor (RORC). Th17 cells also exhibited RORC-dependent CD28 hyperexpression and the ability to produce IL-17A after CD28 stimulation without CD3 triggering. Our findings suggest that the rarity of human Th17 cells in inflamed tissues results from RORC-dependent mechanisms limiting their expansion. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326581     DOI: 10.1016/j.immuni.2011.12.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  42 in total

1.  Human T-Cell Cloning by Limiting Dilution.

Authors:  Laura Maggi; Manuela Capone; Alessio Mazzoni
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Biological and clinical significance of T helper 17 cell plasticity.

Authors:  Alessio Mazzoni; Laura Maggi; Francesco Liotta; Lorenzo Cosmi; Francesco Annunziato
Journal:  Immunology       Date:  2019-10-14       Impact factor: 7.397

Review 3.  Of mice and men: how animal models advance our understanding of T-cell function in RA.

Authors:  Tamás Kobezda; Sheida Ghassemi-Nejad; Katalin Mikecz; Tibor T Glant; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-01-07       Impact factor: 20.543

Review 4.  Amino acid auxotrophy as a system of immunological control nodes.

Authors:  Peter J Murray
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

5.  Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells.

Authors:  Rebeca Jimeno; Javier Leceta; Carmen Martínez; Irene Gutiérrez-Cañas; Mar Carrión; Selene Pérez-García; Marina Garín; Mario Mellado; Rosa P Gomariz; Yasmina Juarranz
Journal:  J Mol Neurosci       Date:  2014-05-08       Impact factor: 3.444

6.  Retinoic acid inhibits CD25+ dendritic cell expansion and γδ T-cell activation in experimental autoimmune uveitis.

Authors:  Dongchun Liang; Aijun Zuo; Hui Shao; Willi K Born; Rebecca L O'Brien; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

Review 7.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

Review 8.  T cells out of control--impaired immune regulation in the inflamed joint.

Authors:  Ellen J Wehrens; Berent J Prakken; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2013-01       Impact factor: 20.543

9.  Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade.

Authors:  Scott M Krummey; Tamara L Floyd; Danya Liu; Maylene E Wagener; Mingqing Song; Mandy L Ford
Journal:  J Immunol       Date:  2014-02-03       Impact factor: 5.422

10.  High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept.

Authors:  S M Krummey; J A Cheeseman; J A Conger; P S Jang; A K Mehta; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2014-03       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.